Ondine Biomedical Statistics
Total Valuation
AIM:OBI has a market cap or net worth of GBP 46.56 million. The enterprise value is 41.23 million.
Market Cap | 46.56M |
Enterprise Value | 41.23M |
Important Dates
The next estimated earnings date is Thursday, September 25, 2025.
Earnings Date | Sep 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AIM:OBI has 443.43 million shares outstanding. The number of shares has increased by 39.31% in one year.
Current Share Class | 443.43M |
Shares Outstanding | 443.43M |
Shares Change (YoY) | +39.31% |
Shares Change (QoQ) | +27.44% |
Owned by Insiders (%) | 36.41% |
Owned by Institutions (%) | 22.58% |
Float | 281.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 40.93 |
PB Ratio | 12.20 |
P/TBV Ratio | 12.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.89 |
EV / Sales | 36.25 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -4.79 |
Financial Position
The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.02.
Current Ratio | 2.05 |
Quick Ratio | 1.73 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | -0.01 |
Interest Coverage | -670.50 |
Financial Efficiency
Return on equity (ROE) is -426.20% and return on invested capital (ROIC) is -251.32%.
Return on Equity (ROE) | -426.20% |
Return on Assets (ROA) | -130.98% |
Return on Invested Capital (ROIC) | -251.32% |
Return on Capital Employed (ROCE) | -282.74% |
Revenue Per Employee | 63,194 |
Profits Per Employee | -589,013 |
Employee Count | 18 |
Asset Turnover | 0.22 |
Inventory Turnover | 0.62 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks. The beta is 0.12, so AIM:OBI's price volatility has been lower than the market average.
Beta (5Y) | 0.12 |
52-Week Price Change | +33.33% |
50-Day Moving Average | 9.06 |
200-Day Moving Average | 8.93 |
Relative Strength Index (RSI) | 64.53 |
Average Volume (20 Days) | 128,067 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:OBI had revenue of GBP 1.14 million and -10.60 million in losses. Loss per share was -0.04.
Revenue | 1.14M |
Gross Profit | 733,351 |
Operating Income | -10.79M |
Pretax Income | -10.60M |
Net Income | -10.60M |
EBITDA | -10.68M |
EBIT | -10.79M |
Loss Per Share | -0.04 |
Balance Sheet
The company has 5.42 million in cash and 93,265 in debt, giving a net cash position of 5.33 million or 0.01 per share.
Cash & Cash Equivalents | 5.42M |
Total Debt | 93,265 |
Net Cash | 5.33M |
Net Cash Per Share | 0.01 |
Equity (Book Value) | 3.82M |
Book Value Per Share | 0.01 |
Working Capital | 3.47M |
Cash Flow
In the last 12 months, operating cash flow was -8.60 million and capital expenditures -5,551, giving a free cash flow of -8.60 million.
Operating Cash Flow | -8.60M |
Capital Expenditures | -5,551 |
Free Cash Flow | -8.60M |
FCF Per Share | -0.02 |
Margins
Gross Margin | 64.47% |
Operating Margin | -948.95% |
Pretax Margin | -932.06% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AIM:OBI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -39.31% |
Shareholder Yield | n/a |
Earnings Yield | -22.77% |
FCF Yield | -18.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AIM:OBI has an Altman Z-Score of -31.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -31.46 |
Piotroski F-Score | 4 |